Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer-Reference-Cited by-同舟云学术

Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer

Published:2019-05 Issue:3 Volume:2 Page:320-328
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Akamatsu Shusuke,Kubota Masashi,Uozumi Ryuji,Narita Shintaro,Takahashi Masahiro,Mitsuzuka Koji,Hatakeyama Shingo,Sakurai Toshihiko,Kawamura Sadafumi,Ishidoya Shigeto,Hoshi Senji,Ishida Masanori,Mizuno Kei,Ogura Keiji,Goto Takayuki,Terada Naoki,Kobayashi Takashi,Yamasaki Toshinari,Inoue Takahiro,Tsuchiya Norihiko,Ohyama Chikara,Arai Yoichi,Habuchi Tomonori,Morita Satoshi,Ogawa Osamu

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference29 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer;Sweeney;N Engl J Med,2015

3. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial;James;Lancet,2016

4. Abiraterone for prostate cancer not previously treated with hormone therapy;James;N Engl J Med,2017

5. Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer;Fizazi;N Engl J Med,2017

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes and Risk Stratification in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With New-Generation Androgen Receptor Signaling Inhibitors;Clinical Genitourinary Cancer;2024-10

2. Predictive model of castration resistance in advanced prostate cancer by machine learning using genetic and clinical data: KYUCOG-1401-A study;BJC Reports;2024-09-09

3. A retrospective study of prognostic factors and prostate-specific antigen dynamics in Japanese patients with metastatic hormone-sensitive prostate cancer who received combined androgen blockade therapy with bicalutamide;International Journal of Clinical Oncology;2024-08-17

4. A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensity;International Journal of Clinical Oncology;2024-07-19

5. From biology to the clinic — exploring liver metastasis in prostate cancer;Nature Reviews Urology;2024-04-26